4-N-Benzoyl-5'-O-(tert-butyldimethylsilyl)-5-[3-(2,2,2-trifluoroacetamido)-prop-1-ynyl]-2'-deoxycytidine
95%
- Product Code: 97191
CAS:
666847-67-2
| Molecular Weight: | 594.7 g./mol | Molecular Formula: | C₂₇H₃₃F₃N₄O₆Si |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8°C, dry, airtight |
Product Description:
This compound is primarily utilized in the field of nucleotide chemistry and medicinal research, particularly in the synthesis of modified nucleosides. Its structure, featuring a trifluoroacetamido group and a tert-butyldimethylsilyl (TBDMS) protecting group, makes it a valuable intermediate in the development of oligonucleotides for therapeutic applications. The trifluoroacetamido moiety enhances stability and reactivity, allowing for precise modifications in nucleic acid sequences. Additionally, the TBDMS group protects the hydroxyl functionality during synthetic processes, ensuring selective reactions. This compound is often employed in the preparation of antisense oligonucleotides, which are used in gene silencing and targeted therapy for genetic disorders and viral infections. Its unique properties also make it suitable for research in drug delivery systems, where modified nucleosides are designed to improve bioavailability and therapeutic efficacy.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | ฿41,184.00 |
+
-
|
4-N-Benzoyl-5'-O-(tert-butyldimethylsilyl)-5-[3-(2,2,2-trifluoroacetamido)-prop-1-ynyl]-2'-deoxycytidine
This compound is primarily utilized in the field of nucleotide chemistry and medicinal research, particularly in the synthesis of modified nucleosides. Its structure, featuring a trifluoroacetamido group and a tert-butyldimethylsilyl (TBDMS) protecting group, makes it a valuable intermediate in the development of oligonucleotides for therapeutic applications. The trifluoroacetamido moiety enhances stability and reactivity, allowing for precise modifications in nucleic acid sequences. Additionally, the TBDMS group protects the hydroxyl functionality during synthetic processes, ensuring selective reactions. This compound is often employed in the preparation of antisense oligonucleotides, which are used in gene silencing and targeted therapy for genetic disorders and viral infections. Its unique properties also make it suitable for research in drug delivery systems, where modified nucleosides are designed to improve bioavailability and therapeutic efficacy.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
฿0.00
฿0.00
Total :